About QSI
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is... [Read more]
Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 159
Stock Exchange NASDAQ
Ticker Symbol QSI
Full Company Profile
Financial Performance
Financial Statements
Analyst Forecast
According to 2 analysts, the average rating for QSI stock is "Buy." The 12-month stock price forecast is $3.0, which is an increase of 105.48% from the latest price.
Price Target
$3.0
(105.48% upside)
Analyst Consensus: Buy
Stock Forecasts
News
Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing™ to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced a presentation by Gloria Sheynkman, Ph....
2 days ago - Business Wire
Quantum-Si Announces Presentations at ASMS and ESHG
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Presentations at ASMS and ESHG.
12 days ago - Business Wire
Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors.
12 days ago - Business Wire
Quantum-Si Reports First Quarter 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced financial results for the first quarter...
4 weeks ago - Business Wire
Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced upgrades to its Platinum® Analysis Soft...
6 weeks ago - Business Wire
Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024.
7 weeks ago - Business Wire
Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a seni...
2 months ago - Business Wire
Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing™ on Platinum® at US HUPO Conference
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (NASDAQ: QSI): WHAT: The Protein Sequencing Company™, Quantum-Si Incorporated, will showcase its Next-Generation Protein Sequencing™ instrumen...
3 months ago - Business Wire
Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing CompanyTM, today announced financial results for the fourth quart...
3 months ago - Business Wire
Renowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb Webinar
--(BUSINESS WIRE)--Quantum-Si Incorporated (NASDAQ: QSI): WHAT: Esteemed scientist Christopher Mason, Ph.D., of Weill Cornell Medicine, is set to discuss his Two Frontiers Project during an exclusive ...
3 months ago - Business Wire
Quantum-Si to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will report financial results f...
4 months ago - Business Wire
Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing™ Platform
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the launch of new platform enhancements...
4 months ago - Business Wire
Quantum-Si Introduces World's First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has entered into an agreement w...
5 months ago - Business Wire
Quantum-Si Expands Global Reach with Addition of New Distributor
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si expands global reach with addition of new distributor.
6 months ago - Business Wire
Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum™ Grows
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum™ Grows.
7 months ago - Business Wire
Quantum-Si Reports Third Quarter 2023 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Third Quarter 2023 Financial Results.
7 months ago - Business Wire
Quantum-Si Honored as Proteomics Company of the Year by the BioTech Breakthrough Awards
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Honored as Proteomics Company of the Year by the BioTech Breakthrough Awards.
7 months ago - Business Wire
Quantum-Si to Participate at Two Upcoming Investor Conferences
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate at Two Upcoming Investor Conferences.
8 months ago - Business Wire
Quantum-Si Presents its Vision to Transform Genomics and Proteomics Research at ASHG 2023
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Presents its Vision to Transform Genomics and Proteomics Research at ASHG 2023.
8 months ago - Business Wire
Quantum-Si to Report Third Quarter 2023 Financial Results on November 9, 2023
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Third Quarter 2023 Financial Results on November 9, 2023.
8 months ago - Business Wire
CORRECTING AND REPLACING Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization
--(BUSINESS WIRE)--Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization.
8 months ago - Business Wire
Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization
--(BUSINESS WIRE)--Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization.
8 months ago - Business Wire
Quantum-Si to Present at The Festival of Genomics & Biodata 2023 in Boston, Massachusetts
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Present at The Festival of Genomics & Biodata 2023 in Boston, Massachusetts.
9 months ago - Business Wire
Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors.
9 months ago - Business Wire
Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4).
10 months ago - Business Wire